MedPath

三才石岐制药股份有限公司

Ownership
-
Established
2010-12-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

155

NMPA:155

Drug Approvals

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H44021287
Approval Date
Jan 31, 2023
NMPA

Chloramphenicol Injection

Product Name
氯霉素注射液
Approval Number
国药准字H44023260
Approval Date
Dec 5, 2022
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H19999327
Approval Date
Nov 15, 2022
NMPA

Ceftazidime for Injection

Product Name
注射用头孢他啶
Approval Number
国药准字H20055694
Approval Date
Nov 15, 2022
NMPA

Cefoperazone Sodium for Injection

Product Name
注射用头孢哌酮钠
Approval Number
国药准字H44023581
Approval Date
Nov 15, 2022
NMPA

Ergometrine Maleate Injection

Product Name
马来酸麦角新碱注射液
Approval Number
国药准字H44023656
Approval Date
Nov 15, 2022
NMPA

Cefradine for Injection

Product Name
注射用头孢拉定
Approval Number
国药准字H44023228
Approval Date
Oct 19, 2022
NMPA

Cytochrome C Injection

Product Name
细胞色素C注射液
Approval Number
国药准字H44023282
Approval Date
Oct 19, 2022
NMPA

Cefradine for Injection

Product Name
注射用头孢拉定
Approval Number
国药准字H44023289
Approval Date
Oct 19, 2022
NMPA

Micronomicin Sulfate Injection

Product Name
硫酸小诺霉素注射液
Approval Number
国药准字H44023655
Approval Date
Oct 19, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.